https://www.selleckchem.com/pr....oducts/chir-99021-ct
xation and reduction technique were favorable, which illustrated that it could be a promising treatment algorithm for such kind of disease.Patients with malignancy may present with significant thromboembolic complications including deep vein thrombosis (DVT), pulmonary embolism, arterial thrombosis, nonbacterial thrombotic endocarditis, and stroke due to abnormal coagulation cascades. Although these events are typically recognized later in the disease process, complications of a hypercoagulable state can rarely present as
Like
Comment
Share
